WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1999014194) 2,3,5-TRISUBSTITUTED PYRIDINES AS INHIBITORS OF CYCLOOXYGENASE-2
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1999/014194    International Application No.:    PCT/CA1998/000862
Publication Date: 25.03.1999 International Filing Date: 11.09.1998
Chapter 2 Demand Filed:    26.01.1999    
IPC:
C07D 213/61 (2006.01), C07D 213/64 (2006.01), C07D 213/70 (2006.01)
Applicants: MERCK FROSST CANADA & Co. [CA/CA]; 16711 Trans-Canada Highway, Kirkland, Quebec H9H 3L1 (CA) (For All Designated States Except US).
FRIESEN, Richard [CA/CA]; (CA) (For US Only).
DUBE, Daniel [CA/CA]; (CA) (For US Only).
DESCHENES, Denis [CA/CA]; (CA) (For US Only).
FORTIN, Rejean [CA/CA]; (CA) (For US Only)
Inventors: FRIESEN, Richard; (CA).
DUBE, Daniel; (CA).
DESCHENES, Denis; (CA).
FORTIN, Rejean; (CA)
Agent: MURPHY, Kevin, P.; Swabey Ogilvy Renault, Suite 1600, 1981 McGill College, Montreal, Quebec H3A 2Y3 (CA)
Priority Data:
60/058,630 12.09.1997 US
9800688.5 14.01.1998 GB
Title (EN) 2,3,5-TRISUBSTITUTED PYRIDINES AS INHIBITORS OF CYCLOOXYGENASE-2
(FR) PYRIDINES 2,3,5-TRISUBSTITUEES UTILISEES COMME INHIBITEURS DE LA CYCLO-OXYGENASE 2
Abstract: front page image
(EN)The invention encompasses the novel compound of Formula (I) as well as a method of treating cyclooxygenase-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula (I). The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula (I).
(FR)L'invention concerne un nouveau composé de formule (I), ainsi qu'une méthode permettant de traiter les maladies ayant pour médiateur la cyclo-oxygénase 2, qui consiste à administrer à un patient ayant besoin dudit traitement une quantité, efficace sur le plan thérapeutique et non toxique, d'un composé de formule (I). L'invention concerne également certaines compositions pharmaceutiques destinées au traitement des maladies ayant pour médiateur la cyclo-oxygénase 2 et renfermant des composés de formule (I).
Designated States: AL, AM, AU, AZ, BA, BB, BG, BR, BY, CA, CN, CU, CZ, EE, GE, HR, HU, ID, IL, IS, JP, KG, KR, KZ, LC, LK, LR, LT, LV, MD, MG, MK, MN, MX, NO, NZ, PL, RO, RU, SG, SI, SK, SL, TJ, TM, TR, TT, UA, US, UZ, VN, YU.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)